Document is current
Any future updates will be listed below
-
Authors
Zyss, Daniel
Sharma, Amritansh
A Ribeiro, Susana
E Repellin, Claire
Lai, Oliver
J C Ludlam, Mary
Walter, Thomas
Fehri, Amin
-
Funding
Funding for this research was provided by:
Ile-de-France Region (DIM ELICIT)
Grand Équipement National De Calcul Intensif (2023—AD011011156R3)
- License Information
-
More Information
Article History
Received: 1 August 2025
Accepted: 1 December 2025
First Online: 27 December 2025
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare the following Conflict of interest. D.Z., S.A.R, C.E.R., O.L., M.J.C.L. and A.F. are shareholders of Cairn Biosciences. T.W. is an advisor to and holds stock options in Cairn Biosciences. Current author affiliations include ORIC Pharmaceuticals and Revolution Medicines; these organizations had no role in this work.
